Nevena Zubcevik Co-Founder and Chief Medical Offi
Post# of 8719
(Total Views: 118)
Posted On: 10/11/2025 6:49:44 PM
Nevena Zubcevik
Co-Founder and Chief Medical Officer
at Electrome Corp
Jan 2025 - Present 10 mos
Harvard Medical School Electrome Corp
Driving clinical strategy and translational research for bioelectric therapeutics targeting inflammation, chronic illness, brain injury, cancer, and regenerative healing.
Overseeing clinical research design, regulatory pathways (FDA 510(k), De Novo), and industry collaborations.
Leading physician and patient education initiatives on the role of bioelectricity in medicine.
Co-authoring IP for novel medical devices and AI-enabled diagnostic/therapeutic discovery platforms.
Serving as a key opinion leader (KOL) and advisor in the medtech and biotech sectors.
Exciting news!
I’m thrilled to share that our startup,
<<<<<<Electrome, is coming out of stealth mode and officially launching this Friday>>>>>>
at the Royal Sonesta Hotel in Cambridge, alongside the Nanobiosym Quantum Convergence Summit at MIT.
Electrome is pioneering the first integrated bioelectric therapeutics platform designed to modulate inflammation, accelerate healing, and target complex conditions including pain, infection, and cancer, all through the language of the body’s own electricity.
You can learn more at electrome.com.
If you’ll be in the Boston area, I’d love to see you at the event or connect with anyone in your network who would be inspired by this next frontier in medicine and technology. You can register for the launch here https://lnkd.in/gw3n8FK3
About
Harvard-trained and board-certified in Physical Medicine and Rehabilitation, I am the Co-Founder and Chief Medical Officer of Electrome, a bioelectric medicine company pioneering non-invasive therapies that restore cellular health through precision modulation of ion channels and membrane potentials. My career bridges academic medicine, biotechnology, clinical innovation, and regulatory strategy, giving me a unique vantage point to translate cutting-edge science into accessible, effective healthcare solutions.
I also serve as Chief Executive Officer of Dhamma Care, a precision medicine clinic, and bring over a decade of leadership in healthcare innovation, patient care, and medical education. I am passionate about building disruptive technologies, cross-disciplinary collaborations, and scalable platforms that advance human health.
Co-Founder and Chief Medical Officer
at Electrome Corp
Jan 2025 - Present 10 mos
Harvard Medical School Electrome Corp
Driving clinical strategy and translational research for bioelectric therapeutics targeting inflammation, chronic illness, brain injury, cancer, and regenerative healing.
Overseeing clinical research design, regulatory pathways (FDA 510(k), De Novo), and industry collaborations.
Leading physician and patient education initiatives on the role of bioelectricity in medicine.
Co-authoring IP for novel medical devices and AI-enabled diagnostic/therapeutic discovery platforms.
Serving as a key opinion leader (KOL) and advisor in the medtech and biotech sectors.
Exciting news!
I’m thrilled to share that our startup,
<<<<<<Electrome, is coming out of stealth mode and officially launching this Friday>>>>>>
at the Royal Sonesta Hotel in Cambridge, alongside the Nanobiosym Quantum Convergence Summit at MIT.
Electrome is pioneering the first integrated bioelectric therapeutics platform designed to modulate inflammation, accelerate healing, and target complex conditions including pain, infection, and cancer, all through the language of the body’s own electricity.
You can learn more at electrome.com.
If you’ll be in the Boston area, I’d love to see you at the event or connect with anyone in your network who would be inspired by this next frontier in medicine and technology. You can register for the launch here https://lnkd.in/gw3n8FK3
About
Harvard-trained and board-certified in Physical Medicine and Rehabilitation, I am the Co-Founder and Chief Medical Officer of Electrome, a bioelectric medicine company pioneering non-invasive therapies that restore cellular health through precision modulation of ion channels and membrane potentials. My career bridges academic medicine, biotechnology, clinical innovation, and regulatory strategy, giving me a unique vantage point to translate cutting-edge science into accessible, effective healthcare solutions.
I also serve as Chief Executive Officer of Dhamma Care, a precision medicine clinic, and bring over a decade of leadership in healthcare innovation, patient care, and medical education. I am passionate about building disruptive technologies, cross-disciplinary collaborations, and scalable platforms that advance human health.
(2)
(0)